4-((4-(Trifluoromethyl)phenyl)amino)benzoic acid, 95+%, 250mg

1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione, 98.0%, 25g

4-Fluoro-2-(trifluoromethyl)benzamide, 97.0%, 1g

N-(benzo[d]thiazol-2-yl)-1,2,3,4-tetrahydroisoquinoline-8-carboxamide dihydrochloride, 97%, 1g

2-(3-Chloro-4-(difluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

(S)-Hexan-2-ol, 97%, 1g

ethyl 2-hydroxy-4-(naphthalen-2-yl)-4-oxobut-2-enoate, 95%, 5g

N-(2-Acetamido)-2-aminoethanesulfonic acid (ACES), 99.0%, 25g

N-(2,2-DIMETHOXYETHYL)-2-(3-METHOXYPHENYL)ACETAMIDE, 95.0%, 2g

7-fluoro-1,2-dihydro-1,8-naphthyridin-2-one, 95+%, 50mg

4-Fluoro-3-nitrophenylacetonitrile, 95.0%, 1g

tert-Butyl (1R*,4R*)-4-(3,3-dimethylbutanamido)cyclohexylcarbamate, 1g

2,3-Dimethylindole>98.0%(GC)25g